
Join to View Full Profile
200 First St SwRochester, MN 55905
Phone+1 507-538-4186
Dr. Ida is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Cristiane Ida is a molecular pathologist and neuropathologist who works at Mayo Clinic in Rochester, MN. She received her medical degree from Universidade de Sao Paulo (Brazil) and has been in clinical practice since 2016. She is board-certified in anatomic pathology, molecular genetic pathology and neuropathology. She is currently one of the laboratory co-directors of the Molecular technologies laboratory and oversees neurooncology genetic testing at Mayo Clinic. Dr. Ida has more than 40 publications and over 500 citings.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Pathology-Anatomic and Clinical, 2010 - 2014
- Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao PauloMD, Anatomic Pathology, 2004 - 2007
- Universidade de Sao Paulo Faculty of MedicineClass of 2003
Certifications & Licensure
- MN State Medical License 2012 - 2025
- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Neuropathology
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- EGFR transcript variants: Potential diagnostic biomarker for glioblastoma, IDH-wildtype?David J Cook, Paul A Decker, Jayson J Hardcastle, Tom M Kollmeyer, Stephanie A Smoley
Journal of Neuropathology and Experimental Neurology. 2025-04-25 - Expanding the spectrum of TERT promoter mutations in CNS tumors: A case series of non-canonical mutations.David J Cook, Jorge A Trejo-Lopez, Beth A Pitel, Neiladri Saha, Tejaswi Koganti
Journal of Neuropathology and Experimental Neurology. 2025-03-19 - Personalized tumor-specific amplified DNA junctions in peripheral blood of patients with glioblastoma.Mohamed F Ali, Cecile Riviere-Cazaux, Sarah H Johnson, Rebecca Salvatori, Alan R Penheiter
Clinical Cancer Research. 2025-02-28
Committees
- member, CAP Neuropathology 2024 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: